Increased Incidence of Mitochondrial Cytochrome C Oxidase 1 Gene Mutations in Patients with Primary Ovarian Insufficiency.

Primary ovarian insufficiency (POI), also known as premature ovarian failure (POF), is defined as more than six months of cessation of menses before the age of 40 years, with two serum follicle stimulating hormone (FSH) levels (at least 1 month apart) falling in the menopause range. The cause of POI...

Full description

Bibliographic Details
Main Authors: Xiumei Zhen, Bailin Wu, Jian Wang, Cuiling Lu, Huafang Gao, Jie Qiao
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4520565?pdf=render
id doaj-2451e72605b34bbfa854fcb3126fd2b3
record_format Article
spelling doaj-2451e72605b34bbfa854fcb3126fd2b32020-11-24T21:39:00ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01107e013261010.1371/journal.pone.0132610Increased Incidence of Mitochondrial Cytochrome C Oxidase 1 Gene Mutations in Patients with Primary Ovarian Insufficiency.Xiumei ZhenBailin WuJian WangCuiling LuHuafang GaoJie QiaoPrimary ovarian insufficiency (POI), also known as premature ovarian failure (POF), is defined as more than six months of cessation of menses before the age of 40 years, with two serum follicle stimulating hormone (FSH) levels (at least 1 month apart) falling in the menopause range. The cause of POI remains undetermined in the majority of cases, although some studies have reported increased levels of reactive oxygen species (ROS) in idiopathic POF. The role of mitochondrial DNA in the pathogenesis of POI has not been studied extensively. This aim of this study was to uncover underlying mitochondrial genetic defects in patients with POI. The entire region of the mitochondrial genome was amplified in subjects with idiopathic POI (n=63) and age-matched healthy female controls (n=63) using nine pair sets of primers, followed by screening of the mitochondrial genome using an Illumina MiSeq. We identified a total of 96 non-synonymous mitochondrial variations in POI patients and 93 non-synonymous variations in control subjects. Of these, 21 (9 in POI and 12 in control) non-synonymous variations had not been reported previously. Eight mitochondrial cytochrome coxidase 1 (MT-CO1) missense variants were identified in POI patients, whereas only four missense mutations were observed in controls. A high incidence of MT-CO1 missense variants were identified in POI patients compared with controls, and the difference between the groups was statistically significant (13/63 vs. 5/63, p=0.042). Our results show that patients with primary ovarian insufficiency exhibit an increased incidence of mitochondrial cytochrome c oxidase 1 gene mutations, suggesting that MT-CO1 gene mutation may be causal in POI.http://europepmc.org/articles/PMC4520565?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Xiumei Zhen
Bailin Wu
Jian Wang
Cuiling Lu
Huafang Gao
Jie Qiao
spellingShingle Xiumei Zhen
Bailin Wu
Jian Wang
Cuiling Lu
Huafang Gao
Jie Qiao
Increased Incidence of Mitochondrial Cytochrome C Oxidase 1 Gene Mutations in Patients with Primary Ovarian Insufficiency.
PLoS ONE
author_facet Xiumei Zhen
Bailin Wu
Jian Wang
Cuiling Lu
Huafang Gao
Jie Qiao
author_sort Xiumei Zhen
title Increased Incidence of Mitochondrial Cytochrome C Oxidase 1 Gene Mutations in Patients with Primary Ovarian Insufficiency.
title_short Increased Incidence of Mitochondrial Cytochrome C Oxidase 1 Gene Mutations in Patients with Primary Ovarian Insufficiency.
title_full Increased Incidence of Mitochondrial Cytochrome C Oxidase 1 Gene Mutations in Patients with Primary Ovarian Insufficiency.
title_fullStr Increased Incidence of Mitochondrial Cytochrome C Oxidase 1 Gene Mutations in Patients with Primary Ovarian Insufficiency.
title_full_unstemmed Increased Incidence of Mitochondrial Cytochrome C Oxidase 1 Gene Mutations in Patients with Primary Ovarian Insufficiency.
title_sort increased incidence of mitochondrial cytochrome c oxidase 1 gene mutations in patients with primary ovarian insufficiency.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2015-01-01
description Primary ovarian insufficiency (POI), also known as premature ovarian failure (POF), is defined as more than six months of cessation of menses before the age of 40 years, with two serum follicle stimulating hormone (FSH) levels (at least 1 month apart) falling in the menopause range. The cause of POI remains undetermined in the majority of cases, although some studies have reported increased levels of reactive oxygen species (ROS) in idiopathic POF. The role of mitochondrial DNA in the pathogenesis of POI has not been studied extensively. This aim of this study was to uncover underlying mitochondrial genetic defects in patients with POI. The entire region of the mitochondrial genome was amplified in subjects with idiopathic POI (n=63) and age-matched healthy female controls (n=63) using nine pair sets of primers, followed by screening of the mitochondrial genome using an Illumina MiSeq. We identified a total of 96 non-synonymous mitochondrial variations in POI patients and 93 non-synonymous variations in control subjects. Of these, 21 (9 in POI and 12 in control) non-synonymous variations had not been reported previously. Eight mitochondrial cytochrome coxidase 1 (MT-CO1) missense variants were identified in POI patients, whereas only four missense mutations were observed in controls. A high incidence of MT-CO1 missense variants were identified in POI patients compared with controls, and the difference between the groups was statistically significant (13/63 vs. 5/63, p=0.042). Our results show that patients with primary ovarian insufficiency exhibit an increased incidence of mitochondrial cytochrome c oxidase 1 gene mutations, suggesting that MT-CO1 gene mutation may be causal in POI.
url http://europepmc.org/articles/PMC4520565?pdf=render
work_keys_str_mv AT xiumeizhen increasedincidenceofmitochondrialcytochromecoxidase1genemutationsinpatientswithprimaryovarianinsufficiency
AT bailinwu increasedincidenceofmitochondrialcytochromecoxidase1genemutationsinpatientswithprimaryovarianinsufficiency
AT jianwang increasedincidenceofmitochondrialcytochromecoxidase1genemutationsinpatientswithprimaryovarianinsufficiency
AT cuilinglu increasedincidenceofmitochondrialcytochromecoxidase1genemutationsinpatientswithprimaryovarianinsufficiency
AT huafanggao increasedincidenceofmitochondrialcytochromecoxidase1genemutationsinpatientswithprimaryovarianinsufficiency
AT jieqiao increasedincidenceofmitochondrialcytochromecoxidase1genemutationsinpatientswithprimaryovarianinsufficiency
_version_ 1725933259816173568